[2022.01] Absology is in the spotlight for in vitro immunodiagnostic devices in the Middle East > news

본문 바로가기
ABSOL VET Contact Us Login
Language
  • · Korean
  • · English

[2022.01] Absology is in the spotlight for in vitro immunodiagnostic d…

본문

17d0386fd624d8128382ea4c8abd66ec_1680591242_908.png

 

[Summary] Absol, a high-sensitivity in vitro immunodiagnostic device developed by Absol (CEO Cho Han Sang), and an animal diagnostic device 'ABSOL VET' are attracting attention in the Middle East.



https://www.dailymedi.com/news/news_view.php?wr_id=879765 

Excerpt from Dailymedi